This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. By the numbers   FY26 Q3 revenue: $9.02 billion 8.7% growth year over year   Cardiovascular revenue: $3.46 billion Nearly 14% growth year over year   Diabetes revenue: $796 million Nearly 15% growth year over year Medtronic said Tuesday that a surgeon completed the first U.S. procedure for its Hugo robotic surgery system, shortly after the company received ...

Industry Overview - The American robotics industry is experiencing significant growth, driven by commercial breakthroughs, venture capital, and FDA approvals, positioning the U.S. as a leader in global automation [1] - The humanoid robotics market is projected to reach $15.26 billion by 2023, with a compound annual growth rate (CAGR) of 39.2% [2] - The global robotics market is expected to grow to $124.37 billion, with the surgical robotics market alone projected to reach $14.45 billion by 2026 [3] Investment Landscape - Global robotics funding surpassed $10.3 billion in 2025, the highest since 2021, with U.S. companies capturing the majority of this investment [3] - Notable funding rounds include Figure AI raising over $1 billion at a valuation of $39 billion and Physical Intelligence securing $400 million from investors [3] - SoftBank's acquisition of ABB's robotics division for $5.375 billion indicates a consolidation trend in the robotics sector [3] Healthcare Robotics - Recent FDA approvals for robotic surgery systems, including Medtronic's Hugo and CMR Surgical's Versius Plus, are expected to accelerate the adoption of healthcare robotics [4] - Johnson & Johnson's Ottava system is advancing through clinical trials, with FDA submission anticipated in early 2026 [4] Defense and Space Applications - The Pentagon allocated $13.4 billion for autonomous systems in its fiscal 2026 budget, with $5.3 billion specifically for unmanned vessels [5] - Upcoming missions, such as NASA's Artemis II and Astrobotic's Griffin lunar mission, will further validate U.S. capabilities in space robotics [5] Collaborative Robotics - The collaborative robotics segment is experiencing over 20% annual growth, with nearly half of small and medium manufacturers now integrating collaborative robots (cobots) [6] - Universal Robots is expanding its manufacturing capabilities, creating over 200 jobs in Michigan [6] Company Highlights - UiPath has transitioned from traditional robotic process automation to AI orchestration, achieving its first GAAP profitable quarter in Q3 of fiscal 2026, with revenues increasing 16% year over year to $411 million [9][10] - NVIDIA unveiled a comprehensive robotics ecosystem at CES 2026, including the Isaac GR00T N1.6 model and the Blackwell-powered Jetson T4000 module, enhancing its position in physical AI [11] - Cadence Design Systems is acquiring Hexagon's Design & Engineering business for $3.18 billion, enhancing its capabilities in robotics simulation [12] - Intuitive Surgical expanded its market presence with FDA clearance for the da Vinci Single Port system for various surgical procedures, supported by over 500 peer-reviewed publications [13]

Industry Overview - The MedTech industry has demonstrated resilience and steady growth through 2025, with the Dow Jones U.S. Select Medical Equipment Index advancing about 8% in 2025, indicating the sector's adaptability and consistent performance despite challenges [1] - The MedTech market was valued at $549.51 billion in 2025 and is projected to reach $853.37 billion by 2035, with a CAGR of 4.5% [5] Growth Drivers for 2026 - Improving fundamentals in the MedTech industry are expected to drive growth in 2026, as procedure volumes normalize and healthcare providers prioritize technologies that enhance clinical outcomes and operational efficiency [2] - The expanding role of artificial intelligence and data-driven solutions is anticipated to be a key growth driver, with the global AI in healthcare market projected to grow from $26.57 billion in 2024 to $505.59 billion by 2033, reflecting a CAGR of 38.81% from 2025 to 2033 [3] - Continued momentum in minimally invasive and robotics-assisted procedures is expected to support MedTech growth, with the global minimally invasive surgery market projected to grow from $94.45 billion in 2025 to $199.3 billion by 2030, reflecting a CAGR of 16.1% [4] Company-Specific Insights Cardinal Health (CAH) - Cardinal Health is a leading healthcare services and products company with a market capitalization of around $48 billion, focusing on pharmaceuticals and medical supplies distribution [6] - The company is positioned for growth in 2026, benefiting from disciplined cost management, pricing actions, and normalization of volumes, with an earnings growth rate for fiscal 2026 pegged at 19.7% [7][9] - CAH's stock has surged more than 71% year-to-date, with a projected revenue increase of 16.2% year-over-year for fiscal 2026 [9] Medtronic (MDT) - Medtronic is a diversified global leader in medical technology, with a strong portfolio across various health conditions and a large installed base [10] - The company reported a revenue increase of approximately 5.5% organically in its latest results, driven by double-digit growth in cardiac ablation solutions [11] - MDT's stock has improved 23.5% year-to-date, with a projected revenue increase of 7.5% year-over-year for fiscal 2026 [12] Intuitive Surgical (ISRG) - Intuitive Surgical is the leader in robotic-assisted minimally invasive surgery, known for its da Vinci Surgical System [13] - The company is poised for growth in 2026 as robotic surgery adoption expands, with an earnings growth rate for 2026 estimated at 11.2% and a projected revenue increase of 14.3% year-over-year [15] - ISRG's stock has grown by 9.7% year-to-date [15] Edwards Lifesciences (EW) - Edwards Lifesciences focuses on structural heart disease and critical care technologies, with a strong reputation in transcatheter aortic valve replacement [16] - The company is expected to benefit from the growing adoption of TAVR procedures, with an earnings growth rate for 2026 estimated at 10.4% and a projected revenue increase of 9.6% year-over-year [18] - EW's stock has improved more than 15% year-to-date [18]